| Name | Enfumafungin |
|---|
| Description | Enfumafungin, a triterpene glycoside, is isolated from extracts derived from an endophytic species of Hormonema. Enfumafungin is an antifungal compound that is acting on the fungal cell wall, as the (1,3)-beta-D-glucan synthase inhibitor. Enfumafungin is specific for yeasts and fungi (excluding Cryptococcus) and does not inhibit the growth of Bacillus subtilis[1][2]. |
|---|---|
| Related Catalog | |
| Target |
(1,3)-beta-D-glucan synthase[1] |
| In Vitro | Enfumafungin (24-48 h) has MICs of less than 0.5 μg/mL against the Candida and Aspergillus species tested and it is inactive against Cryptococcus, including the decapsulated form (MY2062)[1]. |
| In Vivo | Enfumafungin (50-200 mg/kg; i.p. twice daily for 2 days) produces a significant decrease in the number of c.f.u. in kidneys of mice challenged with C. albicans, with an ED90 of 90 mg/kg[1]. |
| References |
| Molecular Formula | C38H60O12 |
|---|---|
| Molecular Weight | 708.88 |
| Hazard Codes | Xi |
|---|